4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000899243-18-017794
President and CEO sold 85,536 shares at an average $9.28 ($793,907)
From the SEC's structured data for this filing
Trades in this filing
Pomerantz Roger · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-06-20 | Sale : show line 1 in the form | −26,492 | $9.33 | $247,051 | 297,812 | D |
| 2018-06-21 | Sale : show line 2 in the form | −18,987 | $9.06 | $172,094 | 278,825 | D |
| 2018-06-22 | Sale : show line 3 in the form | −40,057 | $9.36 | $374,761 | 238,768 | D |
| Open-market sales · 85,536 sh · avg $9.28 · $793,907 | ||||||
Loading xslF345X03/doc4.xml…